STOCKHOLM, SWEDEN / ACCESSWIRE / June 10, 2024 / iZafe Group (STO:IZAFE-B) iZafe Group (publ.) hereby announces that CEO Anders Segerström will present on Tuesday, June 11 at 11:45 AM at Stora Aktiedagarna in Stockholm.
On Tuesday, June 11 at 11:45 AM, iZafe will present its business at Stora Aktiedagarna in Stockholm. The address is Birger Jarlsgatan 61 A. The presentation will also be broadcast live and available afterwards on Aktiespararna’s YouTube channel as well as on iZafe’s website.
More information can be found via this link: https://www.aktiespararna.se/aktiviteter/aktiedagarna-i-stockholm-42149
Contacts
Anders Segerström, Chief Executive Officer
E-mail: anders.segerstrom@izafegroup.com
Phone number: +46 70-875 14 12
iZafe Group AB (publ.)
David Bagares gata 3
111 38 Stockholm
E-mail: ir@izafegroup.com
www.izafegroup.com
eucaps.com/izafe-group
About iZafe Group AB (publ.)
iZafe Group is a Life Science company that conducts research, development and marketing of digital medical solutions and services for safer medication management at home.
The company leads the development of digital drug dispensing through the drug robot Dosell as well as the SaaS solution Pilloxa with the smart pillbox. The company’s solutions reduce the risk of incorrect medication in the home, increase compliance, relieve public health care, increase the quality of life for patients and create a safer environment for relatives.
The customers consist of private individuals, pharmaceutical companies and public and private healthcare providers in Sweden, the Nordics and globally. iZafe Group primarily sells through well-established partners who already have long and deep customer relationships with the prioritized customer groups. The head office is in Stockholm.
iZafe Group AB has been listed on the Nasdaq First North Growth Market since 2018. Mangold Fondkommission AB is the company’s Certified Adviser. Further information is available at www.izafegroup.com
Image Attachments
Attachments
SOURCE: iZafe Group
View the original press release on accesswire.com
PLEASANTON, Calif., Dec. 29, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell…
MESA, Ariz., Dec. 29, 2025 /PRNewswire/ -- Tri-City Cardiology's Ambulatory Surgical Center (ASC), legally referred to…
Collaborative AI-First Ventures Delivers Impactful Solutions for Health, Energy, Small Business and Enterprise SectorsLAS VEGAS,…
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon…
Black Book Market Research issues a global operational alert alongside the release of its 2026…
The leader in sports medicine healing innovations worked with athletes, athletic trainers, physicians and foundations…
